Multidisciplinary Management of Patients with Basal Cell Carcinoma

Article

This publication highlights clinical perspectives on current treatment patterns in BCC, key findings from clinical trials, factors that influence clinical decision making, and opportunities for the development of novel therapies for this patient population.

Related Videos
Erika P. Hamilton, MD
Expert on MM
Related Content
Erika P. Hamilton, MD

Antibody-Drug Conjugates Expand HER2+ Breast Cancer Treatment Options

December 5th 2022
Article
Peter Gibbs, MBBS, MD, FRACP, a medical oncologist at St Vincent’s Private Hospitals and a professor at the University of Melbourne in Australia

MRD Detection Emerges as a Catalyst for Advances in Colon Cancer

December 5th 2022
Article
DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

November 22nd 2022
Article
Shaji Kumar, MD

Biomarker-Directed Therapy in Multiple Myeloma Signals the Future of the Field

September 1st 2022
Article
Treating Patients with Gastric Cancer

Treating Patients with Gastric Cancer

August 25th 2022
Article
Patients with recurrent, platinum-resistant ovarian cancer have limited effective treatment options available, but a class of targeted antibody-drug conjugates represent a promising development for this population.

ADCs Begin to Carve a Place in the Treatment Landscape for Ovarian Cancer

July 20th 2022
Article